BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1339 related articles for article (PubMed ID: 31137992)

  • 1. Trajectories of Blood Lipid Concentrations Over the Adult Life Course and Risk of Cardiovascular Disease and All-Cause Mortality: Observations From the Framingham Study Over 35 Years.
    Duncan MS; Vasan RS; Xanthakis V
    J Am Heart Assoc; 2019 Jun; 8(11):e011433. PubMed ID: 31137992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alirocumab therapy in individuals with type 2 diabetes mellitus and atherosclerotic cardiovascular disease: analysis of the ODYSSEY DM-DYSLIPIDEMIA and DM-INSULIN studies.
    Ray KK; Del Prato S; Müller-Wieland D; Cariou B; Colhoun HM; Tinahones FJ; Domenger C; Letierce A; Mandel J; Samuel R; Bujas-Bobanovic M; Leiter LA
    Cardiovasc Diabetol; 2019 Nov; 18(1):149. PubMed ID: 31706300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is Isolated Low High-Density Lipoprotein Cholesterol a Cardiovascular Disease Risk Factor? New Insights From the Framingham Offspring Study.
    Bartlett J; Predazzi IM; Williams SM; Bush WS; Kim Y; Havas S; Toth PP; Fazio S; Miller M
    Circ Cardiovasc Qual Outcomes; 2016 May; 9(3):206-212. PubMed ID: 27166203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Independent association of atherogenic dyslipidaemia with all-cause mortality in individuals with type 2 diabetes and modifying effect of gender: a prospective cohort study.
    Orsi E; Penno G; Solini A; Bonora E; Fondelli C; Trevisan R; Vedovato M; Cavalot F; Morano S; Baroni MG; Nicolucci A; Pugliese G;
    Cardiovasc Diabetol; 2021 Jan; 20(1):28. PubMed ID: 33516215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trajectories of Lipid Profile and Risk of Carotid Atherosclerosis Progression: A Longitudinal Cohort Study.
    Yu H; Li Y; Tao L; Yang L; Liu D; Wang Y; Hao X; He H; Che Y; Wang P; Zhao W; Gao W
    Nutrients; 2022 Aug; 14(15):. PubMed ID: 35956420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at "Extreme" ASCVD Risk.
    Rosenblit PD
    Curr Diab Rep; 2019 Nov; 19(12):146. PubMed ID: 31754844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipids, Apolipoproteins, and Risk of Atherosclerotic Cardiovascular Disease in Persons With CKD.
    Bajaj A; Xie D; Cedillo-Couvert E; Charleston J; Chen J; Deo R; Feldman HI; Go AS; He J; Horwitz E; Kallem R; Rahman M; Weir MR; Anderson AH; Rader DJ;
    Am J Kidney Dis; 2019 Jun; 73(6):827-836. PubMed ID: 30686529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triglyceride to high-density lipoprotein cholesterol ratio and risk of atherosclerotic cardiovascular disease in a Chinese population.
    Zhou L; Mai J; Li Y; Guo M; Wu Y; Gao X; Wu Y; Liu X; Zhao L
    Nutr Metab Cardiovasc Dis; 2020 Sep; 30(10):1706-1713. PubMed ID: 32811737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-Sensitivity C-Reactive Protein Discordance With Atherogenic Lipid Measures and Incidence of Atherosclerotic Cardiovascular Disease in Primary Prevention: The ARIC Study.
    Quispe R; Michos ED; Martin SS; Puri R; Toth PP; Al Suwaidi J; Banach M; Virani SS; Blumenthal RS; Jones SR; Elshazly MB
    J Am Heart Assoc; 2020 Feb; 9(3):e013600. PubMed ID: 32013698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Association of Low-Density Lipoprotein Cholesterol With Cardiovascular Mortality in Individuals at Low 10-Year Risk of Atherosclerotic Cardiovascular Disease.
    Abdullah SM; Defina LF; Leonard D; Barlow CE; Radford NB; Willis BL; Rohatgi A; McGuire DK; de Lemos JA; Grundy SM; Berry JD; Khera A
    Circulation; 2018 Nov; 138(21):2315-2325. PubMed ID: 30571575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of four lipid components with mortality, myocardial infarction, and stroke in statin-naïve young adults: A nationwide cohort study.
    Lee H; Park JB; Hwang IC; Yoon YE; Park HE; Choi SY; Kim YJ; Cho GY; Han K; Kim HK
    Eur J Prev Cardiol; 2020 May; 27(8):870-881. PubMed ID: 32013600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid profile and incidence of atrial fibrillation: A prospective cohort study in China.
    Li X; Gao L; Wang Z; Guan B; Guan X; Wang B; Han X; Xiao X; Waleed KB; Chandran C; Wu S; Xia Y
    Clin Cardiol; 2018 Mar; 41(3):314-320. PubMed ID: 29575115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total cholesterol/HDL-cholesterol ratio discordance with LDL-cholesterol and non-HDL-cholesterol and incidence of atherosclerotic cardiovascular disease in primary prevention: The ARIC study.
    Quispe R; Elshazly MB; Zhao D; Toth PP; Puri R; Virani SS; Blumenthal RS; Martin SS; Jones SR; Michos ED
    Eur J Prev Cardiol; 2020 Oct; 27(15):1597-1605. PubMed ID: 31291776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of optimal cholesterol levels on subclinical atherosclerosis in the absence of risk factors in young adults.
    Masrouri S; Tamehri Zadeh SS; Shapiro MD; Khalili D; Hadaegh F
    Atherosclerosis; 2024 Jun; 393():117520. PubMed ID: 38616451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small Dense Low-Density Lipoprotein Cholesterol Is the Most Atherogenic Lipoprotein Parameter in the Prospective Framingham Offspring Study.
    Ikezaki H; Lim E; Cupples LA; Liu CT; Asztalos BF; Schaefer EJ
    J Am Heart Assoc; 2021 Feb; 10(5):e019140. PubMed ID: 33586462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between serum lipids and causes of mortality in a cohort of 3,499 urban Thais: The Electricity Generating Authority of Thailand (EGAT) study.
    Sritara P; Patoomanunt P; Woodward M; Narksawat K; Tulyadachanon S; Ratanachaiwong W; Sritara C; Barzi F; Yamwong S; Tanomsup S
    Angiology; 2007 Dec-2008 Jan; 58(6):757-63. PubMed ID: 18216384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond low-density lipoprotein cholesterol: respective contributions of non-high-density lipoprotein cholesterol levels, triglycerides, and the total cholesterol/high-density lipoprotein cholesterol ratio to coronary heart disease risk in apparently healthy men and women.
    Arsenault BJ; Rana JS; Stroes ES; Després JP; Shah PK; Kastelein JJ; Wareham NJ; Boekholdt SM; Khaw KT
    J Am Coll Cardiol; 2009 Dec; 55(1):35-41. PubMed ID: 20117361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid and lipoprotein measurements and the risk of ischemic vascular events: Framingham Study.
    Pikula A; Beiser AS; Wang J; Himali JJ; Kelly-Hayes M; Kase CS; Yang Q; Seshadri S; Wolf PA
    Neurology; 2015 Feb; 84(5):472-9. PubMed ID: 25568296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Appropriate Total cholesterol cut-offs for detection of abnormal LDL cholesterol and non-HDL cholesterol among low cardiovascular risk population.
    Nantsupawat N; Booncharoen A; Wisetborisut A; Jiraporncharoen W; Pinyopornpanish K; Chutarattanakul L; Angkurawaranon C
    Lipids Health Dis; 2019 Jan; 18(1):28. PubMed ID: 30684968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beverage Consumption and Longitudinal Changes in Lipoprotein Concentrations and Incident Dyslipidemia in US Adults: The Framingham Heart Study.
    Haslam DE; Peloso GM; Herman MA; Dupuis J; Lichtenstein AH; Smith CE; McKeown NM
    J Am Heart Assoc; 2020 Mar; 9(5):e014083. PubMed ID: 32098600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 67.